• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.70 -82.90
(-0.33%)
Sensex
81,451.01 -182.01
( -0.22%)
Bank Nifty
55,749.70 203.65
( 0.37%)
Nifty IT
37,321.75 -432.40
( -1.15%)
Global Indices
Nasdaq
42,280.67 43.94
(0.10%)
Dow Jones
5,931.28 -1.89
(-0.03%)
Hang Seng
38,097.61 -335.37
(-0.87%)
Nikkei 225
8,772.38 55.93
(0.64%)
Forex
USD-INR
85.50 0.07
(0.09%)
EUR-INR
97.01 0.42
(0.44%)
GBP-INR
115.18 0.03
(0.03%)
JPY-INR
0.59 0.00
(0.53%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5304659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
153.13
34.18
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

Board of Samvardhana Motherson International approves NCD issuance up to Rs 8,500 cr
May 29,2025
The Board of Samvardhana Motherson International at its meeting held on 29 May 2025 has approved issuance of rated, listed, unsecured, redeemable, non-convertible debentures of face value of Rs 1,00,000/- each, for an aggregate principal amount of up to Rs 8,500 crore, on a private placement basis, in one or more series / tranches to certain eligible investors permitted to invest in the NCDs.